Intel’s COVID-19 Response and Readiness Initiative will provide funding to accelerate customer and partner advances in diagnosis, treatment and vaccine development, leveraging technologies such as artificial intelligence, high-performance computing and edge-to-cloud service delivery.
Honeywell will open a new protective mask manufacturing facility in Phoenix and looks to hire up to 500 people to meet demand as the COVID-19 pandemic spreads throughout the United States.
In response to the COVID-19 pandemic, Intel Corporation announced that it will source and donate more than 1 million items of personal protective equipment – masks, gloves and other gear – to healthcare workers. The tech giant will donate masks, gloves, face shields and other gear that they have sourced from its factory stock and emergency supplies, and will continue to look for additional sources of personal protective equipment to donate as quickly as possible.
As new cases of COVID-19 are being confirmed across the globe, here’s what you need to know about the fast-spreading respiratory virus that causes it.
You’ve no doubt had your fill of conjecture and fear from media coverage of the coronavirus. From the Centers for Disease Control to our own Gov. Doug Ducey, we’re getting the latest news on the few who are affected and what the vast majority of us should be doing to take care of ourselves. What gives me cause for confidence is knowing the solutions to this situation will come through innovation.
Practicing social distancing does not require us to separate from the communities we belong to. The exact opposite is true. Now is the time to strengthen your network of employees, vendors, industry peers and customers. Because our standard ways of interacting are on hold and our businesses are stressed in new and different ways, the best thing we can do is cooperate and support one another. Communicate, assist, and be flexible.
TGen’s work in solving disease outbreaks and building genomic surveillance and detection systems. This work includes designing rapid, highly accurate and cost-effective tests for critical pathogens —such as Valley Fever, MRSA and other hospital superbugs, influenza, tuberculosis — finding and describing new disease pathogens, and detecting outbreaks at the earliest possible timepoints and tracking the evolution of these pathogens.
On the heels of a study showing how cancer can be precisely detected by a liquid biopsy blood test created by the Translational Genomics Research Institute (TGen), a new $2.1 million federal grant will enable TGen and Mayo Clinic researchers to fine-tune the system in clinical trials.
Health Information Management Systems, a leading provider of electronic health record (EHR) software with a unique focus on the integrated health care market, announced it joined the Strategic Health Information Exchange Collaborative (SHIEC) as a Strategic Business and Technology (SB&T) Partner.
Support will propel TGen’s plans for a clinical trial to study new treatments for ovarian cancer, and to support TGen’s Center for Rare Childhood Disorders, including funds for genetic sequencing, which helps doctors diagnose pediatric patients.